X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (570) 570
Publication (47) 47
Book Review (18) 18
Book Chapter (3) 3
Dissertation (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (303) 303
galantamine (301) 301
humans (283) 283
index medicus (253) 253
galantamine - pharmacology (241) 241
cholinesterase inhibitors - pharmacology (204) 204
alzheimer's disease (202) 202
male (197) 197
alzheimers-disease (186) 186
pharmacology & pharmacy (171) 171
alzheimer disease - drug therapy (169) 169
galanthamine (148) 148
rats (143) 143
neurosciences (140) 140
donepezil (122) 122
cholinesterase inhibitors - therapeutic use (118) 118
acetylcholinesterase - metabolism (116) 116
galantamine - therapeutic use (116) 116
female (113) 113
rivastigmine (112) 112
acetylcholinesterase (88) 88
aged (83) 83
dose-response relationship, drug (80) 80
dementia (77) 77
mice (77) 77
alzheimer disease - metabolism (66) 66
brain - drug effects (65) 65
chemistry, medicinal (64) 64
receptors, nicotinic - metabolism (64) 64
placebo-controlled trial (62) 62
brain (61) 61
acetylcholine - metabolism (57) 57
biochemistry & molecular biology (56) 56
cholinesterase inhibitors (54) 54
cholinesterase inhibitors - chemistry (53) 53
clinical neurology (53) 53
galantamine - administration & dosage (53) 53
nicotinic acetylcholine-receptors (52) 52
brain - metabolism (48) 48
disease models, animal (47) 47
treatment outcome (47) 47
acetylcholine (46) 46
double-blind (46) 46
acetylcholinesterase inhibitors (45) 45
rats, sprague-dawley (44) 44
galantamine - chemistry (43) 43
psychiatry (43) 43
drug therapy (41) 41
galantamine - metabolism (41) 41
cholinesterase inhibitors - administration & dosage (40) 40
piperidines - pharmacology (40) 40
rats, wistar (40) 40
middle aged (39) 39
indans - pharmacology (38) 38
piperidines - therapeutic use (38) 38
time factors (38) 38
indans - therapeutic use (37) 37
analysis (36) 36
cholinesterase-inhibitors (36) 36
neurons (36) 36
neuroprotective agents - pharmacology (36) 36
nicotinic receptors (36) 36
aged, 80 and over (35) 35
alzheimer disease - physiopathology (35) 35
structure-activity relationship (34) 34
cholinesterase inhibitors - adverse effects (33) 33
cholinesterase inhibitors - pharmacokinetics (33) 33
galantamine - pharmacokinetics (33) 33
hippocampus - drug effects (33) 33
neurons - drug effects (33) 33
receptors, nicotinic - drug effects (33) 33
drugs (32) 32
galantamine - adverse effects (32) 32
memantine (32) 32
alkaloids (31) 31
amyloid beta-peptides - metabolism (31) 31
binding sites (31) 31
efficacy (31) 31
oxidative stress (31) 31
research (31) 31
geriatrics & gerontology (30) 30
in-vitro (30) 30
inhibition (30) 30
nootropic agents - therapeutic use (30) 30
inhibitors (29) 29
neurodegenerative diseases (29) 29
cholinesterase inhibitors - metabolism (28) 28
cognition - drug effects (28) 28
memory (28) 28
cognition disorders - drug therapy (27) 27
neuropsychological tests (27) 27
acetylcholinesterase inhibitor (26) 26
alzheimer disease - enzymology (26) 26
alzheimer’s disease (26) 26
analysis of variance (26) 26
butyrylcholinesterase (26) 26
in vitro techniques (26) 26
neuroprotection (26) 26
alzheimers disease (25) 25
molecular structure (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (536) 536
Russian (20) 20
Japanese (8) 8
German (4) 4
Chinese (2) 2
French (2) 2
Spanish (2) 2
Bulgarian (1) 1
Finnish (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, pp. e0134648 - e0134648
The cholinergic anti-inflammatory pathway is one of the putative biochemical pathways that link diabetes with Alzheimer disease. Hence, we aimed to verify the... 
WNT SIGNALING PATHWAY | ACETYLCHOLINESTERASE ACTIVITY | IMPROVED GLUCOSE-HOMEOSTASIS | OXIDATIVE STRESS | INSULIN-RESISTANCE | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | DENSITY-LIPOPROTEIN | TYPE-2 DIABETES-MELLITUS | NF-KAPPA-B | CHOLINESTERASE INHIBITOR | Diabetes Mellitus, Experimental - drug therapy | Body Weight | Apoptosis - drug effects | Caspase 3 - metabolism | Muscle, Skeletal - metabolism | Adipokines - blood | Galantamine - pharmacology | Brain - metabolism | Liver - drug effects | Lipids - blood | Muscle, Skeletal - drug effects | Diabetes Mellitus, Experimental - metabolism | Disease Models, Animal | Glucose Tolerance Test | Cytochromes c - metabolism | Liver - metabolism | Inflammation Mediators - blood | Rats | Biomarkers - blood | Hypoglycemic Agents - pharmacology | Brain - drug effects | Insulin - metabolism | Animals | Wnt Signaling Pathway - drug effects | Cholinesterase Inhibitors - pharmacology | Signal Transduction - drug effects | Lipid Metabolism - drug effects | Glucose - metabolism | Blood Glucose - metabolism | Antioxidants | Hypoglycemic agents | Glucose | Galanthamine | Body weight | Dextrose | Cytochrome | Oxidative stress | Wnt protein | Galantamine | Liver | Homeostasis | AKT protein | Diabetic neuropathy | Caspase-3 | Adiponectin | Signal transduction | Toxicology | Pathways | Rodents | Tumor necrosis factor-TNF | Water intakes | Alzheimer's disease | Drug dosages | Glucose transporter | NF-κB protein | Liver diseases | Parameters | Neurodegenerative diseases | Diabetes mellitus | Organs | Muscles | Caspase | Inflammation | Tumor necrosis factor-α | Metabolism | Insulin | Cholinesterase | Molecular chains | Serum levels | Cytochrome c | Signaling | Food intake | Pharmacy | Water intake | Insulin resistance | Diabetes | Laboratory animals | Apoptosis | Index Medicus
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 03/2019, Volume 846, pp. 63 - 72
Journal Article
Journal Article
Journal Article
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 03/2011, Volume 39, Issue 3, pp. 402 - 411
Journal Article
Neuropharmacology, ISSN 0028-3908, 07/2014, Volume 82, pp. 11 - 18
Journal Article
Hippocampus, ISSN 1050-9631, 09/2011, Volume 21, Issue 9, pp. 999 - 1009
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 2013, Volume 33, Issue 37, pp. 14908 - 14920
Journal Article
Pharmaceutical Biology, ISSN 1388-0209, 01/2017, Volume 55, Issue 1, pp. 381 - 393
Context: Grewia tiliaefolia Vahl. (Tiliaceae) is a sub-tropical plant used as an indigenous medicine in India. However, its efficacy has not been evaluated... 
docking | aggregation | neurotoxicity | Antioxidant | Alzheimer's disease | Aggregation | Docking | Neurotoxicity | Alzheimer’s disease | OXIDATIVE STRESS | EFFICACY | ALZHEIMERS-DISEASE | RATS | PLANT SCIENCES | ACETYLCHOLINESTERASE | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | GALANTAMINE | MEDICAL LABORATORY TECHNOLOGY | BRAIN | Free Radical Scavengers - pharmacology | Neurons - pathology | Plant Extracts - pharmacology | Solvents - chemistry | Apigenin - isolation & purification | Plant Leaves | Structure-Activity Relationship | Neuroprotective Agents - metabolism | Dose-Response Relationship, Drug | Plaque, Amyloid | Plant Extracts - metabolism | Neuroprotective Agents - pharmacology | Cholinesterase Inhibitors - metabolism | Butyrylcholinesterase - metabolism | Mass Spectrometry | Amyloid beta-Peptides - metabolism | Chromatography, Liquid | Cholinesterase Inhibitors - isolation & purification | Neurons - metabolism | Phytotherapy | Neurons - drug effects | Peptide Fragments - metabolism | Oxidation-Reduction | Plant Extracts - isolation & purification | Acetylcholinesterase - chemistry | Free Radical Scavengers - isolation & purification | Protein Aggregation, Pathological | Animals | Cholinesterase Inhibitors - pharmacology | Neuroprotective Agents - isolation & purification | Cell Line, Tumor | Protein Binding | Protein Conformation | Mice | Molecular Docking Simulation | Grewia - chemistry | Acetylcholinesterase - metabolism | Apigenin - pharmacology | Plants, Medicinal | Antioxidants | Herbal medicine | Enzymes | Oxidative stress | Neurosciences | Metabolites | Pathogenesis | Clinical trials | Alzheimers disease | Pharmaceuticals | Dementia
Journal Article